Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of Efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons
Mary van den Berg-Wolf, Katherine Huppler Hullsiek, Grace Peng, Michael J. Kozal, Richard M. Novak, Li Chen, Lawrence R. Crane, Rodger D. MacArthur
Dive into the research topics of 'Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of Efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons'. Together they form a unique fingerprint.